Every day, patients make choices that directly impact their health and well being. They choose between taking their medication or leaving it on the counter. When prescriptions run low, they decide whether to make an extra stop at the pharmacy or to put off their refill for one more day.
Patients are looking for meaningful support from the pharmaceutical companies that serve them, and you can provide it with the HealthPrize platform. Our technology uses gamification, education, behavioral economics, and rewards to motivate patients to create and maintain healthy habits. And, since these patient decisions have a direct impact on the business goals of pharma, HealthPrize benefits both patients and the companies that serve them.
HealthPrize programs average 52% lifts in adherence over a brand’s baseline. In many cases, this translates to 2-3 additional prescription fills per year.
Pharmaceutical marketers use HealthPrize to create digital patient experiences that improve adherence, increase health literacy, and provide brand differentiation. Our platform powers and advances patient engagement for branded and generic medications across all drugs, diseases, demographics and dosages.
We deliver best-in-class results because we’re committed to building a best-in-class team of life science experts, health and behavioral change educators, developers and UI technicians, all focused on developing a platform that makes it easier to form and keep healthy habits.
Vice President of Marketing & Communications LinkedIn
Christine Cianni Mayer
Vice President of Operations LinkedIn
Board of Directors
Michael Griffith Executive Chairman
Operating Partner, Altamont Capital Partners. Previously President of the Commercial Division of inVentiv Health LinkedIn
W. Robert Dahl
Previously Co-founder and Chief Operating Officer of investment company Arrowhawk Capital Partners, and the VP of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. LinkedIn
President and CEO of Semaphore. Previously a senior executive at Euromoney Institutional Investor and Fairfield Whitney. LinkedIn
Principal at ZS Associates. Previously EVP, Digital Strategy and Analytics, Saatchi & Saatchi Healthcare and Saatchi & Saatchi Wellness. LinkedIn
Previously General Counsel, Chief Administrative Officer and Executive Vice President, AIG Financial Products Corp. LinkedIn
Kevin Jones Board Observer
Co-founder and CEO of Ambio Health. Previously Managing Director of Alumni Capital Network, LLC. LinkedIn
Board of Advisors
Senior advisor at Triple Tree Capital Partners; Board member of Imagescan, Explorys, and The Human Fund; advisor to the Cleveland Clinic Foundation and Partners Health LinkedIn
Recent past Chairman of the Ambassadors Group, a socially conscious student education travel company; previously acted as Chief Operating Officer of RxAnte (acquired by Millenium Labs LinkedIn
Expert and public speaker on the subject of gamification, user engagement and behavioral design and co-founder of the behavior change software startup, Onward. LinkedIn
Michael Lewis, CFA
Management consultant providing strategic and financial advice to healthcare companies and healthcare investment firms; former Head of Strategy and Business Development at Prodigy Health, a $600M Aetna subsidiary
September 17, 2019
HealthPrize Introduces Max, a Medication Adherence Experience Targeting the Most Common Chronic Conditions
Built using HealthPrize’s technology platform and based on peer-reviewed science and consumer marketing best practices, Max brings to pharma the three key ingredients for adherence success: the patient, the platform and the results.
HealthPrize launches Drive, a new product to simplify and optimize development of adherence programs for pharmaceutical brands
Programs built with Drive apply HealthPrize’s proven approach of gamification, behavioral economics and loyalty marketing to boost patient adherence to their medications for chronic disease
Top Pharmaceutical Companies Can Achieve the Pharmaceutical Triple Aim with Improved Medication Adherence, New Report Shows
New data show how pharmaceutical companies can increase revenue and boost earnings per share with improved adherence, published by HealthPrize Technologies and CEEK Enterprises
HealthPrize Technologies Surpasses One Million Enrolled Users
HealthPrize Technologies today announced a major milestone as it surpassed one million patients enrolled in programs developed on its platform. This breakthrough comes at a time of significant growth for the digital health company.
Boehringer Ingelheim and HealthPrize Expand Successful Digital Patient Support Program
Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.
HealthPrize Technologies Wins 2018 Frost & Sullivan Technology Leadership Award
The digital adherence and patient engagement platform is recognized by Frost for improving patient outcomes and solving business challenges.